Compounds > sparfloxacin
Page last updated: 2024-08-24

sparfloxacin and Acquired Immune Deficiency Syndrome

sparfloxacin has been researched along with Acquired Immune Deficiency Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bollet, C; de Lamballerie, X; de Micco, P; Gevaudan, MJ; Mallet, MN; Sambuc, R1
Hadley, WK; Nassos, PS; Sanders, CA; Yajko, DM1

Other Studies

2 other study(ies) available for sparfloxacin and Acquired Immune Deficiency Syndrome

ArticleYear
[Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
    Pathologie-biologie, 1992, Volume: 40, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Mycobacterium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Opportunistic Infections; Quinolones; Rifabutin; Rifamycins

1992
In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Ciprofloxacin; Drug Synergism; Ethambutol; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin

1990